Arctic Bioscience – CFO change
Arctic Bioscience, a biotech company developing and commercializing pharmaceutical and nutraceutical products based on the unique properties of bioactive marine compounds, announces that CFO Danielle Glenn has terminated her consulting agreement and accepted a position with another company. Glenn has been with the company since September 2020. The search for a new permanent CFO has been initiated.“Arctic Bioscience has taken major steps over the past years, with several initiatives in both pharma and nutraceuticals and the development of a new production facility at the North- West coast of